Individual-level prediction of stroke risk following risperidone treatment in dementia: a mixed methods study
Funder: National Institute for Health and Care ResearchDuration: -
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Dr Byron Creese Director of Research (Principal investigator)
T: +44 (0)1895 265623
E: byron.creese@brunel.ac.uk |
+44 (0)1895 265623 | byron.creese@brunel.ac.uk | Quad North 146 |
Outputs
Creese, B., Macfarlane, D., Ballard, CG., Choma, NJ., Ding, J., Henley, WE., et al. (2025) 'Atypical antipsychotic prescription for agitation in care homes: A qualitative study exploring views of residents, relatives and health and social care professionals'.The Alzheimer’s Association International Conference (AAIC25). Toronto, Canada. 25 - 31 July. Wiley. pp. e104461 - e104461. ISSN: 1552-5260 Open Access Link
Choma, J., Griffiths, A., Henley, W., Mueller, C., Williams, N., Ballard, C., et al. (2025) 'Risk of stroke associated with risperidone in dementia with and without comorbid cardiovascular disease: population-based matched cohort study'. British Journal of Psychiatry, 0 (ahead of print). pp. 1 - 7. ISSN: 0007-1250 Open Access Link